Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced that the U.S. Food and Drug Administration has granted Fast ...

These two clearances mark an important step forward for Bioventus and represent a substantial growth opportunity as the Company looks to expand in the PNS market, which is currently estimated to be ...

In a breakthrough for cardiovascular medicine, researchers have harnessed artificial intelligence to discover unexpected ...

The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.

FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...

FuturHealth, a leading provider of personalized weight-loss solutions, today announced it is giving its members seamless ...

Dr. Vinay Prasad is stepping down as the Food and Drug Administration's top vaccine regulator after a brief tenure.

The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...

A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized ...

Van Der Beek is opening up about his colon cancer to increase awareness of the importance of early detection, especially as ...

Funding will support commercialization in the USA and Europe as well as continued development of MAGENTIQ COLO's advanced AI ...

DelveInsight's THR-β Agonist Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...